The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8436035 B1

PDF
Full Text
Expired
Date of Patent:
May. 07, 2013

Filed:

Dec. 14, 2007
Applicants:

Christopher Adams, Somerville, MA (US);

Qi-ying HU, Needham, MA (US);

Gary Michael Ksander, Amherst, NH (US);

Julien Papillon, Somerville, MA (US);

Inventors:

Christopher Adams, Somerville, MA (US);

Qi-Ying Hu, Needham, MA (US);

Gary Michael Ksander, Amherst, NH (US);

Julien Papillon, Somerville, MA (US);

Assignee:

Novartis AG, Basel, CH;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/4174 (2006.01); C07D 233/64 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention provides a compound of formula I: said compound is inhibitor of aldosterone synthase (CYP11B2), and/or 11 beta-hydroxylase (CYP11B1), and/or aromatase, and thus can be employed for the treatment of a disorder or disease mediated by aldosterone synthase, aromatase, or CYP11B1. Accordingly, the compound of formula I can be used in treatment of hypokalemia, hypertension, congestive heart failure, renal failure, in particular, chronic renal failure, restenosis, atherosclerosis, syndrome X, obesity, nephropathy, post-myocardial infarction, coronary heart diseases, increased formation of collagen, fibrosis and remodeling following hypertension and endothelial dysfunction. Finally, the present invention also provides a pharmaceutical composition.


Find Patent Forward Citations

Loading…